Dr Mark Alan Boarini X, DDS | |
800 Main St, Antioch, IL 60002-1542 | |
(847) 395-1461 | |
Not Available |
Full Name | Dr Mark Alan Boarini X |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 800 Main St, Antioch, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700936846 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Alan Boarini X, DDS 800 Main St, Antioch, IL 60002-1542 Ph: (847) 395-1461 | Dr Mark Alan Boarini X, DDS 800 Main St, Antioch, IL 60002-1542 Ph: (847) 395-1461 |
News Archive
With the third and largest of the U.S. tobacco companies planning an e-cigarette product launch this fall, this next frontier for "Big Tobacco" provides renewed presence in a declining marketplace. It's also a potential gateway to new smokers, particularly among teens and in emerging/foreign markets, according to behavioral scientists at The University of Texas MD Anderson Cancer Center.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
New Zealand's Lake Alice hospital near Bulls in Rangitikei, which used to be self sufficient rural psychiatric set up housing the criminally insane since 1950 has been shut down since October 1999 and since then the hospital has been shrouded in controversies and plans for rebuilding and setting up new units.
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
› Verified 5 days ago
Dr. Lorelei Lynne Grise', D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 439 Lake St, Antioch, IL 60002 Phone: 847-395-3250 Fax: 847-395-4045 | |
Dr. Jeffrey P. Miles, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 417 E Il Route 173, Suite 113, Antioch, IL 60002 Phone: 847-395-5550 Fax: 847-395-5575 | |
Jeff Bang, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 421 Il-173, Antioch, IL 60002 Phone: 224-788-7348 | |
Dr. Brandon B Wood, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1326 Main St Ste A, Antioch, IL 60002 Phone: 847-395-6166 | |
Dr. Daniel J Boarini, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 800 Main St, Antioch, IL 60002 Phone: 847-395-1461 Fax: 847-395-9255 | |
Dr. Kenneth Jazdzewski, DDS Dentist Medicare: Medicare Enrolled Practice Location: 800 Main St, Antioch, IL 60002 Phone: 847-395-1461 Fax: 847-395-9255 | |
Dr. Yousif Tolla, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 550 E Il Route 173, Antioch, IL 60002 Phone: 248-872-0192 |